We're pleased to announce an update is coming to the community boards.
Sunday, September 25th: We are migrating the boards to a new platform. The site is currently in read-only mode and we will bring it back online as soon as the migration is complete.
Could you provide an executive summary of what you were trying to convey? I have in interest in these companies and your input will be appreciated.Sure. I noticed that Matt's post was a tough read as well. I accumulated quite a bit of data (FY 96, 97 and 98 as well as each quarter of 97-99. Here are the summarized numbers:Pfizer DSO high 81 days -- Q4 98 and Q2 99DSO low 65 days -- Q4 97DIO high 341 days -- Q2 99DIO low 237 days -- Q4 97DPO low 102 days -- Q4 97DPO high 171 days -- Q2 97CCC high 277 days -- Q2 99CCC low 184 days -- FY 96Warner-Lambert DSO high 68 days -- Q1 97DSO low 44 days -- Q4 98DIO high 129 days -- Q3 98DIO low 99 days -- FY 96DPO low 90 days -- Q1 97DPO high 226 days -- Q1 99CCC high 86 days -- Q1 97CCC low -60 days -- Q1 99Schering-PloughDSO high 45 days -- Q1 99DSO low 31 days -- FY 98, Q4 98, Q3 98, Q3 97DIO high 207 days -- Q3 97DIO low 159 days -- Q2 98DPO low 160 days -- Q2 97DPO high 226 days -- Q2 98CCC high 83 days -- Q2 97* CCC low -5 days -- Q4 98, FY 98* Seems to be an aberration as next highest is 54 days.On a trend basis Pfizer is consistently higher than the others. It clearly is the weakest in this comparison.Schering is the most consistent (notice the generally smaller ranges. WLA has shown the most improvement primarily due the the change in DPO.Phil
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |